What are biosimilars?

Essential steps to help health systems better prepare for disruptions.

By McKesson Health Systems Editorial Team

Date

February 14, 2022

By: McKesson MedSurg Editorial Team

Read time: 5 minutes

There are important differences between biosimilars and biologics. research and studies show that the use of biosimilar drugs can save money for both patients and providers, and increased affordability of biosimilars can have a meaningful impact on the healthcare system.

To dive deeper into the differences, examining the costs and benefits, Derek Burns and Tim Ho, clinical specialists at McKesson, share their insights on biosimilars and discuss their expert knowledge of these new products.

Two lab professionals in white coats review documents and tablet in a pharmacy or lab setting with shelves of bottles in background.

Redefining Pharmacy’s Workforce for a More Complex Care Era

As care delivery grows more complex, health system pharmacists must expand their skill sets to deliver the patient-centered experiences modern healthcare demands.

Professionals walk through a glass office lobby carrying bags and talking in small groups

Upcoming Event: HealthTrust University Conference

Connect with McKesson at HealthTrust to achieve more for the business of pharmacy through alignment and action

Pharmacy staff member reviews medication box on shelf, holding device while standing in a stocked pharmacy aisle.

Where High-Performing Specialty Pharmacies Focus Today

Successful specialty pharmacies require continuous monitoring and deliberate refinement, especially across these five areas.

People walking and talking in a modern open office lobby, some holding notebooks and badges, viewed from above.

Upcoming Event: 340B Coalition Summer Conference

Connect with our 340B experts to navigate policy complexity and achieve more for the business of pharmacy

Healthcare worker inserts IV line into a person's hand as the person sits with arm resting in a clinic setting.

3 Ways to Evolve Your Infusion Strategy

In the face of rapid change and growth, health systems must rethink their infusion services. Our Health System Pharmacy Market Outlook Report for 2026 outlines three ways health systems are taking action.

Group of business professionals walk and talk in a bright glass hallway, some holding folders and coffee, moving between offices.

Upcoming Event: THMA Pharmacy Growth Collaborative

Executive dialogue and peer-driven insights shaping the future of health system pharmacy

Two business professionals shake hands in a bright office while three colleagues stand behind them holding documents.

2026 Asembia Summit Highlights the Value of Connection Across Specialty, Data, and Partnerships

Engagement across customers, manufacturers, and partners reinforces the importance of collaboration in advancing specialty pharmacy

Microphone on a stand at a panel discussion, with seated speakers and gesturing hands out of focus in the background.

Optimizing Pharmaceutical Supply Chain and Inventory Management: Insights from Becker’s Healthcare Annual Meeting

Explore key takeaways and insights from our recent discussion with health system leaders.

IV infusion bag on a stand in the foreground, with two seated people in a clinical room in the background.

The Infusion Perfect Storm: A Defining Moment in Health System Infusion Strategy?

Health systems infusion services may be entering a period of accelerated transformation and the window for strategic repositioning could be narrowing. Are you ready?

People networking in a bright atrium, standing by glass railings and talking in small groups.

Upcoming Event: Navigating the Future of Specialty Pharmacy at AXS26

Connect with our industry leaders at Asembia to discover strategies to help you achieve more.

What are biosimilars?

Related Stories

Related Tags